Corporate News – Houlihan Lokey Inc. (HLI)
Market Performance Snapshot
During the 24‑hour period ending at 05:54 PM Central Europe on Thursday 22 October 2026, the shares of Houlihan Lokey Inc. (ticker HLI) declined by 1.49 %, closing at USD 132.26 on major exchanges. The company’s current market capitalisation stands at USD 9.1 billion, with a circulating supply of 69.9 million shares.
In the last 24 hours, roughly USD 74.2 million worth of HLI shares were traded. Compared with the previous month‑end, the stock has fallen 1.97 %. The simple moving average over the last 200 trading days is USD 146.29. The 52‑week high and low for HLI are USD 204.18 (28 October 2025) and USD 112.83 (30 July 2026), respectively.
Share Buy‑back Programme
On 25 August 2026, HLI announced a daily buy‑back of its ordinary fully paid shares. The programme, conducted on market, will continue until 31 December 2026 and may purchase up to 27 million shares unless shareholders approve a larger amount.
UBS Securities Australia Limited has been appointed as broker, and the buy‑back will be paid in Australian dollars. Daily notifications will be filed in accordance with ASX listing rules. The company reserves the right to vary, suspend, or terminate the programme subject to regulatory approval. This move underscores HLI’s commitment to returning value to shareholders while maintaining compliance with disclosure obligations.
Related Stocks in the Last 24 Hours
| Symbol | Change | Price (USD) | Market Cap (USD bn) | P/E Ratio |
|---|---|---|---|---|
| Globalstar (GSAT) | +0.02 % | 82.69 | 10.8 | – |
| BioMarin Pharmaceutical (BMRN) | –2.18 % | 56.08 | 10.8 | 148.44 |
| Fidelity National (FNF) | +0.30 % | 40.88 | 10.9 | 14.15 |
| Freddie Mac (FHL.SG) | +1.28 % | 4.00 | 10.9 | – |
| Jack Henry & Associates (JKHY) | –0.84 % | 161.06 | 10.9 | 22.12 |
BioMarin has attracted renewed analyst attention, with several reports assigning a “Strong Buy” rating. The consensus among 23 analysts suggests a notable upside, driven by the company’s focus on rare, genetically inherited disorders. Jack Henry & Associates announced the recipients of its 2026 Cobalt Awards, recognising six financial institutions and fintechs that have leveraged technology to improve operational efficiency and client outcomes. The firm also scheduled a webcast of its first‑quarter fiscal 2027 earnings call for early November.
Company Overview
Houlihan Lokey Inc. is a global investment bank headquartered in the United States, operating within the Financials sector. The firm specialises in mergers and acquisitions, financial restructuring, capital markets, strategic consulting, and financial advisory services. Listed on the New York Stock Exchange since its IPO on 13 August 2015, HLI serves a worldwide client base through its website, www.hl.com .